October 30, 2019
Vertex Reports Third-Quarter 2019 Financial Results
– Product revenues of $950 million, a 21% increase compared to Q3 2018 – – Continued progression of pipeline of…
Pharmaceuticals, Biotechnology and Life Sciences
– Product revenues of $950 million, a 21% increase compared to Q3 2018 – – Continued progression of pipeline of…
Company Also Receives CE Mark for the VASCADE MVP for Multi-Site Vessel Closure Following Electrophysiology Procedures SANTA CLARA, Calif.–(BUSINESS WIRE)–Cardiva…
Serial entrepreneur and computer scientist Bryan Brandenburg advances biomedical and life extension simulation and visualization AI technologies at the helm…
RALEIGH, N.C.–(BUSINESS WIRE)–Arrevus Inc. (www.arrevus.com), a biotechnology company developing novel therapeutics for patients with unmet medical needs, today announced the…
Dendreon has completed enrollment of of 450 patients, in Phase 3 ProVent clinical trial testing Sipuleucel-T in men on active…
Providing new patient treatment options, accelerating development of life-changing medicines
NOTTINGHAM, England–(BUSINESS WIRE)–Tufts Center for the Study of Drug Development (CSDD) today published a white paper sharing study results that…
Trial Will Evaluate Safety and Efficacy of the Company’s Trappsol® Cyclo™ Drug in Alzheimer’s Disease GAINESVILLE, Fla.–(BUSINESS WIRE)–Cyclo Therapeutics, Inc.…
LAVAL, Quebec–(BUSINESS WIRE)–#Altasciences–On behalf of the sponsor, Acurx Pharmaceuticals, Altasciences is proud to have successfully completed the clinical conduct,…
DARTMOUTH, Nova Scotia–(BUSINESS WIRE)–IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical-stage biopharmaceutical company pioneering a novel class of immunotherapies, today…